Chinese Herbal Medicine Liu Jun Zi Tang and Xiang Sha Liu Jun Zi Tang for Functional Dyspepsia: Meta-Analysis of Randomized Controlled Trials

Table 4

Odds ratios (OR) and summary OR for Xiang Sha Liu Jun Zi Tang (XSLJZT) trials. OR and their 95% confidence intervals are presented with weighting in a fixed effect model. OR > 1.0 indicates that the symptomatic improvement of functional dyspepsia is higher in the XSLJZT group than that in prokinetic drugs group.

Study or subgroup	XSLJZT		Prokinetic drugs			Odds ratio	Odds ratio
	Events	Total	Events	Total	Wight	M-H, fixed, 95% Cl	M-H, fixed, 95% Cl
Chen 2005 [13]	58	65	29	40	14.2%	3.14 [1.10, 8.96]
Fan 2010 [16]	27	30	21	30	7.7%	3.86 [0.93,16.05]
Gui 2003 [14]	35	40	29	40	13.3%	2.66 [0.83, 8.52]
Li 2004 [15]	32	36	26	36	10.6%	3.08 [0.86,10.95]
Li 2010 [22]	30	32	25	32	5.8%	4.20 [0.80, 22.06]
Liang 2011 [25]	28	30	25	32	5.9%	3.92 [0.74, 20.65]
Lu and Hong 2012 [17]	32	34	29	34	6.3%	2.76 [0.50,15.33]
Xiao 2005 [21]	29	39	30	38	28.7%	0.77 [0.27, 2.23]
Zhou 2010 [26]	27	30	20	30	7.4%	4.50 [1.09, 18.50]
Total (95% Cl)		336		312	100.0%	2.63 [1.72, 4.03]
Total events	298		234
Heterogeneity: Chi^2 = 6.65, df = 8 (P = 0.57); 𝐼^2 = 0%
Test for overall effect: Z = 4.44 (P < 0.00001)